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Abstract 
Background: Plasmid expression is a popular method in studies of MVA pathway for isoprenoid production in 
Escherichia coli. However, heterologous gene expression with plasmid is often not stable and might burden growth of 
host cells, decreases cell mass and product yield. In this study, MVA pathway was divided into three modules, and two 
heterologous modules were integrated into the E. coli chromosome. These modules were individually modulated with 
regulatory parts to optimize efficiency of the pathway in terms of downstream isoprenoid production.
Results: MVA pathway modules Hmg1-erg12 operon and mvaS-mvaA-mavD1 operon were integrated into E. coli 
chromosome followed by modulation with promoters with varied strength. Along with activation of atoB, a 26% 
increase of β-carotene production with no effect on cell growth was obtained. With a combinatory modulation of 
two key enzymes mvas and Hmg1 with degenerate RBS library, β-carotene showed a further increase of 51%.
Conclusions: Our study provides a novel strategy for improving production of a target compound through integra-
tion and modulation of heterologous pathways in both transcription and translation level. In addition, a genetically 
hard-coded chassis with both efficient MEP and MVA pathways for isoprenoid precursor supply was constructed in 
this work.
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Background
Isoprenoids, also referred to as terpenes or terpenoids, 
are the most diverse class of natural products consisting 
of over 55,000 structurally different compounds, which 
has lots of applications in pharmaceuticals, nutraceu-
ticals, cosmetics and food [1–4]. These valuable com-
pounds are commonly isolated from plant, microbes and 
marine organisms. But the supply of these compounds 
has been limited by scarce resources from which they 
were originally extracted. Production by chemical syn-
thesis is uneconomical due to the complex structure of 
these products [1]. For these reasons, microbial meta-
bolic engineering has been explored in the past dec-
ade for isoprenoid production, including artemisinin, 
limonene paclitaxel (Taxol), astaxanthin, β-carotene and 
lycopene etc. [5–8].
Isoprenoids are all derived from two five-carbon build-
ing blocks called isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP), which are syn-
thesized either by the mevalonate (MVA) pathway in 
eukaryotes, archaea, and some bacteria or 2-C-methyl-
d-erythritol-4-phosphate (MEP) pathway in other 
prokaryotes and plastids in plants [2, 3, 9]. In the past 
15 years, to increase the yield of terpene production, con-
siderable effort has been focused on improving precursor 
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supply by overexpression or deletion of upstream path-
way genes, and altering global metabolic network by 
rational strategies or random mutagenesis [10–12]. 
MEP pathway has been engineered to increase IPP and 
DMAPP in E. coli for increased synthesis of carotenoids. 
Yuan et al. showed that four enzymes in the MEP path-
way were rate limiting [13]. Similarly, when intrinsic dxs 
and idi were modulated by artificial modulation parts, 
the resultant strains had increased β-carotene produc-
tion [14]. On the other hand, to address precursor IPP/
DMAPP limitations in E. coli, heterologous MVA path-
way genes were overexpressed using plasmid to improve 
isoprenoid production [15–19]. Higher isoprenoid 
production were achieved by strains equiped with the 
bottom portion of MVA pathway of Streptococcus pneu-
moniae, and cultured in media with MVA supplementa-
tion [18, 19]. Lycopene production of E. coli harboring 
the whole MVA pathway from Streptomyces sp. CL190 
was two-fold higher than strain with only native MEP 
pathway [16]. However, high-level expression of meva-
lonate pathway enzymes might inhibit cell growth. Pitera 
et. al found that accumulation of MVA pathway interme-
diate 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-
CoA) inhibited cell growth with overexpressed atoB, 
mvaS and hmg1 [20]. Mevalonate kinase (MK), encoded 
by erg12, was identified as another rate-limiting enzyme 
when the MVA pathway was used to increase in amor-
phadiene production [21].
To balance MVA pathway flux, it is necessary to express 
the HMG-CoA reductase and MK at a higher level to 
decrease accumulation of HMG-CoA, and to eliminate 
the rate-limiting step. In our previous work, β-carotene 
synthetic gene operon (crtEXYIB) from P. agglomerans 
CGMCC No. 1.2244 controlled by trc promoter and 
rrnB transcriptional terminator was integrated into wild 
type E. coli ATCC 8739 at ldhA site, resulting in strain 
QL002. The inducible promoter of crtEXYIB in QL002 
was replaced with strong constitutive promoter M1-12 
to obtain strain QL105. Activation of dxs, idi genes and 
crt operon in QL105 led to increase of β-carotene pro-
duction, and the resulting stain was named CAR001 
[14]. In this study, the MVA pathway genes were divided 
into three modules, (i) hmg1 and erg12, which need to 
be expressed at high level, (ii) atoB, which is an endog-
enous gene of E. coli, and (iii) mvaS, mvaA and mvaD1, 
which are the other genes of the MVA pathway (Fig. 1a). 
The objective of the study was to increase β-carotene 
production by integrating heterologous genes of MVA 
pathway into E. coli chromosome as two operons, modu-
late involved heterologous and endogenous genes indi-
vidually, as well as illustrate relationship between gene 
expression level and β-carotene production in hyper pro-
ducer strain.
Methods
Strains, medium and growth conditions
Strains used in this study are listed in Additional file  1: 
Table S6. During strain construction, cultures were 
grown aerobically at 30, 37, or 39 °C in Luria broth (per 
liter: 10 g Difco tryptone, 5 g Difco yeast extract and 5 g 
NaCl). For β-carotene production, single colonies were 
picked from the plate and inoculated into 15 × 100 mm 
tubes containing 4 ml LB with or without 34 mg/l chlo-
ramphenicol and 100 mg/l ampicillin, and grown at 30 °C 
and 250 rpm overnight. Seed culture was then inoculated 
into 100  ml flask containing 10  ml LB, with or without 
34  mg/l chloramphenicol and 100  mg/l ampicillin (with 
an initial OD600 of 0.05), and grown at 30 °C and 250 rpm. 
After 24 h growth, cells were collected for measurement 
of β-carotene production. For strains using trc promoter 
for induction of MVA pathway genes, 1  mM IPTG was 
added for induction 3  h after inoculation, followed by 
21 h growth [14].
Construction of plasmids for expressing MVA pathway 
genes
All plasmids used in this study are listed in Additional 
file 1: Table S5. The Hmg1 and erg12 genes, which need 
be expressed at high level, were placed in one operon; 
while mvas, mvaA and mavD1 genes were put in another 
operon (Fig. 1a). Hmg1 and erg12 were isolated by PCR 
with Pfu DNA polymerase (NEB) from chromosomal 
DNA of Saccharomyces cerevisiae. Individual genes were 
spliced together (sequence named as He) using overlap-
ping extensions from primers HMG1-XmaI-f, HMG1-
r, ERG12-f, ERG12-SalI-r (Additional file  1: Table S1). 
mvas, mvaA and mavD1 genes were isolated and spliced 
together (sequence named as Mmm) by overlapping 
extensions from primers ERG13-BamHI-f, ERG13-r, 
ERG8-f, ERG8-r, MVD1-f and MVD1-SalI-r (Additional 
file  1: Table S1). Plasmid pTrc99A-M were digested 
by XmaI and SalI ligated by T4 DNA ligase, and trans-
formed into Trans T1 competent cells (Transgen, Bei-
jing, CN). Plasmid carrying Hmg1 and erg12 genes was 
screened, selected and designated as pTrc99A-M-He 
(Fig.  1b). mvas, mvaA and mavD1 genes were inserted 
into pACYC184-M at BamHI and SalI site using the 
same method, and the plasmid was designated as 
pACYC184-M-Mmm.
Integration of MVA genes into E. coli chromosome
A two-step homologous recombination method [22, 23] 
was used to integrate Hmg1-erg12 operon into E. coli 
CAR001 [14] at pflB site, and the mvaS-mvaA-mavD1 
operon at frdB site (Fig.  1c). pflB gene was amplified 
from genomic DNA of E. coli ATCC 8739 using primer 
set pflB-up/pflB-down (Additional file  1: Table S1), and 
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cloned into pEASY-Blunt (Transgen, Beijing, CN) to 
produce plasmid pXZ014 (Additional file 1: Table S5). A 
1000-fold dilution of this plasmid DNA served as tem-
plate for inside-out amplification using the pflB-1/pflB-2 
primer set (Additional file  1: Table S1). The resulting 
4735  bp fragment containing replicon was ligated with 
cat-sacB cassette from pXZ-CS [24] to produce pXZ015C 
(Additional file  1: Table S5). PCR fragment amplified 
from pXZ014 was ligated with the Hmg1-erg12 operon, 
which was amplified from pTrc99A-M-He with prime 
set HMG1-XmaI-f/99A-r (Additional file  1: Table S1), 
to produce plasmid pQL003-He (Additional file 1: Table 
S5). A two-step recombination method was developed 
for markerless recombination of Hmg1-erg12 operon 
expression in CAR001 at pflB site (Additional file 1: Fig-
ure S1). In the first recombination, cat-sacB cassette was 
amplified from pXZ015C with primer set pflB-up/pflB-
down (Additional file  1: Table S1), treated with DpnI, 
and electroporated into competent CAR001 with pKD46. 
After overnight growth on LB plate with 34  mg/l chlo-
ramphenicol and 100  mg/l ampicillin at 30  °C, several 
colonies were picked for PCR verification using primer 
set cat-up/pflB-down (Additional file 1: Table S1). In the 
second recombination, Hmg1-erg12 operon with rrnB 
terminator were amplified from pQL003-He with a same 
primer set pflB-up/pflB-down (Additional file  1: Table 
S1), and used to replace cat-sacB cassette by selection for 
resistance to sucrose. Cells containing sacB gene accu-
mulated levan during incubation with sucrose and were 
eliminated. With this mechanism, survived recombinants 
were highly enriched for colonies without cat-sacB cas-
sette [22, 23]. The resulting strain was designated as 
atoB





E. coli dxs dxr ispD ispE ispG ispH
b 
a




Fig. 1 Genes used for β-carotene synthesis in engineered E. coli strains, vector constructs and the two artificial MVA operons. a Genes involved 
in β-carotene Production via both MEP and MVA pathways. The abbreviations for enzymes and pathway intermediates are as follows: atoB, gene 
of acetoacetyl-CoA thiolase; mvaS, gene of HMG-CoA synthase; Hmg1, truncated HMG-CoA reductase; erg12, gene of mevalonate kinase; mvaA, 
gene of HMG-CoA reductase; mvaD1, gene of mevalonate pyrophosphate decarboxylase; idi, gene of IPP isomerase; ispA, FPP synthase; crtEYIB, 
β-carotene synthesis operon from Pantoea agglomerans; b Plasmid maps of vectors with heterologous MVA genes; c Integrated artificial MVA path-
way operons in E. coli chromosome at pflB and frdB sites
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CAR006. Plasmid pQL006-Mmm was constructed using 
the same method as pQL003-He. mvaS-mvaA-mavD1 
operon was inserted into frdB site using the same method 
as integration of Hmg1-erg12 operon. The primers used 
are listed in Additional file 1: Table S1. Plasmids are listed 
in Additional file 1: Table S5.
Two‑step recombination method for markerless 
modulation of gene expression
A two-step recombination method was used for marker-
less modulation of gene expression, which was beneficial 
for multiple rounds of genome editing [25]. Hmg1-erg12 
operon was first modulated in CAR006 using this method 
(Additional file 1: Figure S2). In the first recombination, 
cat-sacB cassette was amplified with primer set pflB-up-
cat/Hmg1-sacB-down (Additional file  1: Table S1) for 
insertion at upstream of Hmg1-erg12 operon. In the sec-
ond recombination, different artificial regulatory parts 
(M1-46 and M1-93, whose strengths were 2.5 and 5 times 
of induced E. coli lacZ when cultivated in LB medium 
[26]) were amplified with a same primer set pflB-up-P/
Hmg1-RBS-down (Additional file  1: Table S1) and used 
to replace cat-sacB cassette by selection for resistance to 
sucrose. Markerless modulation of other genes was the 
same as Hmg1-erg12 operon, and primers used are listed 
in Additional file 1: Table S1. Resulting strains are listed 
in Additional file 1: Table S6.
One‑step recombination method for modulating mvas 
and Hmg1 expression with RBS library
mvas of CAR012 was modulated with RBS library using 
a one-step recombination method as described previ-
ously [26, 27]. Regulatory parts M1-93 was PCR tem-
plate for RBS library. The artificial regulatory parts with 
different resistance gene were constructed to be used as 
templates for RBS library construction, so that different 
genes can be modulated in a one strain with resistance 
genes intact. For construction of M1-cam-93, a chlo-
ramphenicol resistance gene fragment followed by 50 
nucleotides homologous sequence of FRT in M1-93 was 
amplified from plasmid pXZ-CS using primer set FRT-
cam-up/FRT-cam-down (Additional file  1: Table S1), 
and electroporated into competent M1-93 with pKD46. 
After overnight growth on LB plate with 34  mg/l chlo-
ramphenicol, several colonies were picked for PCR veri-
fication using primer set Cat-g-up/LacZ-373 (Additional 
file  1: Table S1). The obtained strain was designated 
M1-cam-93, as listed in Additional file 1: Table S6.
Apramycin resistance regulatory parts construction 
was the same as M1-cam-93, primers are listed in Addi-
tional file 1: Table S1, and the resultant strain was desig-
nated as M1-Apr-93 (Additional file 1: Table S6).
A one-step homologous recombination method was 
used to further modulate mvas and Hmg1 gene with RBS 
Library. For modulating mvas, DNA fragments were 
amplified from genomic DNA of M1-cam-93 with primer 
set frdB-up-FRT/Mvas-RBSL-down (Additional file  1: 
Table S2). Primer Mvas-RBSL-down was degenerated 
with six bp random sequence at RBS site (NNNNNNYC) 
[28]. The resulting PCR product was a degenerated RBS 
library, and electroporated into competent E. coli CAR012 
with pKD46. After overnight growth on LB plate with 
34 mg/l chloramphenicol, fifteen colonies were picked for 
PCR verification using primer set Cat-g-up/MvaS-350-r 
(Additional file 1: Table S1). Fifteen correct colonies were 
randomly selected and designated from mvaS-RBSL-1 to 
mvaS-RBSL-15 (Additional file  1: Table S6), β-carotene 
production of which were measured (Additional file  1: 
Table S6). Hmg1 was modulated with RBS Library in the 
same way of the mvas, except that the RBS library was 
PCR amplified from M1-Apr-93 with apramycin resist-
ance gene. Primers are listed in Additional file 1: Table S1 
and strains are listed in Additional file 1: Table S6.
To further increase the β-carotene production, Hmg1 
gene of the Hmg1-erg12 operon in the best strain mvaS-
RBSL-13 was also modulated with the RBS Library. In 
addition, a ten-colony-strain mixture randomly selected 
from mvaS-RBS Library was also used as parent strain 
pool for Hmg1 modulation. Fifteen colonies from each 
resulted library were randomly selected for measuring 
β-carotene production (Additional file 1: Table S6).
Measurement of β‑carotene production
Production of β-carotene was quantified by measuring 
absorption of acetone-extracted β-carotene at 453  nm 
as previously reported [14]. One millililitre of cells cul-
tured for β-carotene production were harvested by cen-
trifugation at 4000 rpm for 10 min, suspended in acetone 
(1 ml), and incubated at 55 °C for 15 min in dark. Sam-
ples were then centrifuged at 14,000  rpm for 10  min 
to obtain supernatant containing β-carotene, whose 
absorbance was measured at 453  nm using a Shimadzu 
UV-2550 spectrophotometer (Shimadzu, Kyoto, Japan). 
The β-carotene production was normalized to the cell 
density. The results represented the mean ± SD of three 
independent experiments.
Calculation of mvaS and Hmg1 RBS strength of strains 
from Re‑modulation libraries
RBS sequences along with their context region of mvaS 
and Hmg1 in representative strains were sequenced. 
Their theoretical RBS strength characterized by the value 
of translation initiation rate was calculated with the RBS 
library calculator [29, 30].
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Results
β‑carotene production by E coli with heterologous 
expression of MVA pathway
To eliminate growth inhibition caused by imbalanced 
overexpression of MVA pathway gene, the heterologous 
MVA pathway genes from S. cerevisiae were separated 
into two portions and cloned into plasmids pTrac99A-M 
and pACYC184-M, respectively. pACYC184-M-Mmm 
containing mvaS-mvaA-mavD1 operon and pTrac99A-
M-He containing Hmg1-erg12 operon were first trans-
formed into QL105 and CAR001 [14]. Optimization of 
MEP pathway in QL105 led to increased β-carotene pro-
duction, and the resulting strain was CAR001 (Fig.  2). 
Both strains were used as parent strains to compare 
effects of addition of MVA pathway in present of native 
and engineered MEP pathway. After culturing with IPTG 
induction, β-carotene yields of the resulting strain QL105 
(pACYC184-M-Mmm, pTrac99A-M-He) and CAR001 
(pACYC184-M-Mmm, pTrac99A-M-He) were 1.45-, 
1.47-fold of the initial strain (Fig.  2b). Meanwhile, the 
expression of MVA pathway genes on plasmids caused a 
12 and 27% decrease in cell mass for QL105 and CAR001, 
respectively (Fig.  2a). The result showed that the 
β-carotene production of the native MEP pathway did 
not affect introduction of heterologous MVA pathway, 
in terms of β-carotene production. Growth defect was 
observed in engineered strains, which were probably due 
to plasmid burden or imbalanced MVA pathway. In addi-
tion, 90% of the plasmid bearing strains lost resistance 
after 24 h of culturing, indicating loss of their plasmids.
Improved β‑carotene production by Integration MVA 
pathway genes into E. coli and expression modulation
In order to eliminate possible growth burden caused by 
plasmids and obtain genetically stable strains, the Hmg1-
erg12 operon without promoter was integrated into 
chromosome of CAR001 at pflB site, resulting in strain 
CAR006. Then, this operon was modulated with two 
regulatory parts (M1-46 and M1-93), resulting in strains 
CAR007 and CAR008 (Additional file 1: Table S6). Plas-
mid pACYC184-M-Mmm was transformed into CAR007 
and CAR008 to complement MVA pathway. In the result-
ing strains, the cell mass decreased by nearly 20%, while 
the β-carotene yield was 1.26- and 1.17-fold that of strain 
CAR001 respectively (Table  1). To integrate the whole 
MVA pathway into E. coli chromosome, operon of mvaS-
mvaA-mavD1 genes without promoter was integrated 
into CAR007 at frdB site, resulting in strain CAR009. 
This operon was then modulated with two regulatory 
parts (M1-46 and M1-93), resulting strains CAR010 
and CAR011 (Additional file  1: Table S6). In the result-
ing strains, the cell mass decreased by nearly 20%, and 
the β-carotene yield was only 1.03- and 1.02-fold that of 
CAR001 respectively (Table  1), suggesting imbalanced 
expression of the MVA pathway in these two strains.
Improved β‑carotene production by modulation of atoB 
gene expression
Escherichia coli is known to contain only low levels of 
acetoacetyl-CoA [20, 31], which may be the reason for 
the low β-carotene production of CAR010 and CAR011. 
To improve β-carotene production, atoB of CAR010 was 
modulated with three regulatory parts (M1-46, M1-37 
and M1-93), which were characterized constitutive pro-
moters with different transcription efficiency [26]. The 
best strain CAR012 with atoB expressed by M1-37 had a 
β-carotene production 1.26-fold that of CAR001 (Table 1).
Further improvement by re‑modulation of MVA pathway 
genes
Although modulation of all the MVA pathway genes in 
strain CAR012 with regulatory parts led to an increase 
Fig. 2 Cell mass and relative β-carotene production by E. coli strains with or without MVA pathway. a Cell mass. b Relative β-carotene production. 
β-carotene yield was compared to the parent strain QL105 and CAR001. Three repeats were performed for each strain, and the error bars repre-
sented standard deviation
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in β-carotene production, the increase was only 26%, and 
the regulatory parts of two operons of the MVA pathway 
were the same (M1-46). Strengths of these regulatory 
parts might not be optimal for β-carotene production, 
suggesting a possibility of obtaining a higher β-carotene 
production by modulating the expression of these impor-
tant genes with different artificial regulatory parts.
With this strategy, mvas gene of the mvas-mvaA-mavD1 
operon was modulated firstly with an RBS library. Fif-
teen colonies were randomly selected from the library for 
measuring β-carotene production (Additional file 1: Table 
S6), the β-carotene yield ranged from 1.07 to 1.36 times 
and cell mass ranged from 0.94 to 1.15 times of CAR001 
(Fig.  3). The best strain mvaS-RBSL-13, produced 8% 
higher than CAR012 and 36% higher than CAR001.
To further increase the β-carotene production, Hmg1 
gene of the Hmg1-erg12 operon in the best strain mvaS-
RBSL-13 was also modulated with the RBS library. In 
addition, a ten-colony-strain mixture randomly selected 
from mvaS-RBS Library was used as a parent strain pool 
for Hmg1 modulation. Two new libraries were obtained, 
and fifteen colonies from each library were randomly 
selected for measuring β-carotene production (Addi-
tional file  1: Table S6). The resulting β-carotene yield 
ranged from 0.93 to 1.51 times and cell mass ranged from 
0.90 to 0.98 times of CAR001 (Fig. 4).
Gray columns in Fig. 4 represent E. coli strains from RBS 
modulated library of mvaS-RBSL-13, which had β-carotene 
yield ranged from 0.93 to 1.34 times of CAR001. Most 
strains had a titer between 0.93 and 1.09 times of CAR001. 
Black columns represent strains from the RBS modulated 
library of mvaS-RBSL-mix. Their β-carotene yield ranged 
from 1.04 to 1.51 times of CAR001, and were mostly 
between 1.09 and 1.51 times of CAR001. This result sug-
gested that a RBS modulated library from a mixture of 
strains might be more ideal than those from a single regula-
tory part, probably due to having more possible regulation 
patterns. The cell mass of best strains Hmg1-RBSL-M10 
was 0.99 times of that of CAR001, which demonstrated 
that balanced MVA pathway restored growth of the strain 
Table 1 Integration and modulation of MVA pathway genes for improving β-carotene production
a Three repeats were performed for each strain, and the error bars represented standard deviation
b Acetone-extracted β-carotene solution was concentrated 2 times for measuring the absorption at 453 nm
Strainsa OD600 OD
b
453 OD453/OD600 Increase of β‑carotene yield‑ CAR001
QL105 4.22 ± 0.15 0.27 ± 0.01 0.06 ± 0.01
CAR001 4.05 ± 0.10 2.36 ± 0.06 0.58 ± 0.00 1.00 ± 0.00
CAR007 (184-EEM) 3.31 ± 0.05 2.43 ± 0.13 0.73 ± 0.04 1.26 ± 0.06
CAR008 (184-EEM) 3.32 ± 0.07 2.26 ± 0.09 0.68 ± 0.04 1.17 ± 0.07
CAR010 4.05 ± 0.05 2.45 ± 0.07 0.60 ± 0.01 1.03 ± 0.02
CAR011 4.11 ± 0.07 2.43 ± 0.05 0.59 ± 0.02 1.02 ± 0.03
CAR012 4.01 ± 0.07 2.93 ± 0.20 0.73 ± 0.05 1.26 ± 0.09
CAR013 3.91 ± 0.11 2.41 ± 0.12 0.62 ± 0.03 1.07 ± 0.05
Fig. 3 Cell mass and relative β-carotene production by E. coli strains after modulating mvas expression with RBS library in CAR012
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(Additional file  1: Table S3). In addition, β-carotene pro-
duction of best strain Hmg1-RBSL-M10 increased 51% 
compared with CAR001 (Figs. 4, 5).
Hmg1-RBSL-M10 culture after 48  h fermenta-
tion was spread on LB agar plates for measurement of 
genetic stability. It was found that 100% colonies show-
ing orange color which was the color of β-carotene. This 
demonstrated the stability of strains with chromosomal 
integrated heterologous genes. In comparison, when 
plasmids were used as expression vector we found that 
90% strains lost resistance after 24 h of culturing.
Analysis of mvaS and Hmg1 RBS strength of strains 
from re‑modulation libraries
RBS strength was analyzed with the RBS calculator [29, 
30] to find the relationship between mvaS and Hmg1 
expression status and β-carotene production. Calculated 
RBS strength was represented by the translation initiation 
rate and listed in Table 2 and Additional file 1: Table S7. 
The RBS strength is by no means a very accurate measure-
ment of the expression status of mvaS and Hmg1, however, 
could give a good estimate of general trend of and opti-
mized regulation pattern of MVA pathway. According to 
the data, a medium to low expression of both mvaS and 
Hmg1 improved the efficiency of MVA pathway. The best 
strain carries the third weakest mvaS RBS and the middle 
level of hmg1 RBS (Additional file 1: Table S7). Since mvaS 
and Hmg1 are closest to the promoter and had higher tran-
scription than other genes, the weaker RBSs might help 
to balance their expression with other genes in the same 
operon, which suggested an overall balanced expression of 
MVA pathway genes was beneficial with its efficiency.
Discussion
In MVA pathway, accumulation of the intermediate 
3-hydroxy-3-glutaryl-CoA (HMG-CoA) was found to 
cause inhibition of cell growth [20]. It is necessary to 
reduce expression of mvaS and increase Hmg1, which 
encodes HMG-CoA reductase, for reduction of HMG-
CoA accumulation. The mevalonate should be rapidly 
converted into mevalonate-5 phosphate by mevalonate 
kinase (MK) or it would cross cell membrane and dif-
fuse into medium [20]. MK is also one of the rate-limiting 
enzymes [21]. To facilitate modulation of these genes and 
balance their expression to keep pathway intermediates 
at a proper level in host cells, MVA pathway was divided 
and engineered as three separately expressed operons in 
this work. This strategy was proved to be effective with 
increased β-carotene production.
Fig. 4 Cell mass and relative production by E. coli strains with modulation of Hmg1 expression with RBS library from mvaS-RBSL-13 or mvaS-RBSL-











Integrate heterologous genes of MVA 
pathway into E. coli at pflB site and frdB 
site, and modulated with M1-46; 
Modulate atoB gene with M1-37 
Modulate mvas gene with RBS library  
Modulate Hmg1 gene with RBS 
library  
1.51 
Fig. 5 Diagram summarizing steps in the metabolic engineering of E. 
coli for β-carotene production in this work
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Plasmid overexpression of the MVA pathway genes 
was previously utilized to increase isoprenoid produc-
tion in E. coli, but caused metabolic burden in host and 
led to reduced cell growth [32]. In this study, the five 
heterologous genes of MVA pathway were first cloned 
into two compatible plasmids, and expressed in QL105 
and CAR001 strains. The growth of strains with plasmid 
had one quarter decrease compared to the initial strains 
(Fig. 2). In our work, the growth burden was eliminated 
by integration and of these genes into E. coli chromosome 
followed by modulation. This result indicated that over-
expression of heterologous genes with chromosome inte-
grated form was a better strategy than plasmid expression.
Strong promoters have been generally used to over-
express genes for improved carotenoid production [13, 
33, 34]. However, they might not be optimal to obtain 
maximum metabolic flux towards desired products 
[35]. Previous studies indicated that better production 
could be obtained by modulating genes with regulatory 
parts of varied strengths. dxs gene of MEP pathway was 
modulated by several artificial promoters, and an optimal 
strength for improved lycopene production was identi-
fied [36]. Similarly, glyceraldehyde-3-phosphate dehy-
drogenase gene (gapA) was modulated by three artificial 
promoters to achieve an optimal strength for glycerol 
production [37]. In both cases, the optimal expression 
strength was not the strongest one. A similar result 
was obtained in this work. In the strain with highest 
β-carotene production, two MVA operons (mvas-mvaD-
mvaA and Hmg1-erg12) were expressed with a medium 
strength promoters M1-46, and atoB was expressed with 
a weak promoter M1-37. In addition, key enzymes mvas 
and Hmg1 were under control of medium to weak RBSs. 
Thus, previous reports and our results suggested an 
overall balanced expression of MVA pathway genes was 
relatively efficient, which might also be true for most het-
erologous pathways.
One of the most important research subjects of meta-
bolic engineering is pursuing a balanced metabolic 
pathway. In recent years, several combinatorial pathway 
engineering strategies and methods were established [38, 
39]. In this work we dedicated to develop and apply a rel-
atively simple method for pathway balancing and produc-
tion improvement. Firstly, operons were modulated with 
limited number of promoters, which were previously 
defined; then genes within an operon were combinatori-
ally modulated with RBS libraries for multiple rounds. To 
reduce library size and simplify screening, limited num-
ber of strains from previous round were picked as parent 
strains for next round of modulation with RBS library. By 
compromising with the goal of finding the most balanced 
pathways, this method requires minimal lab work for 
finding a reasonably efficient pathway. In this work, mod-
ulating mvaS with RBS libraries led to 36% improvement 
of β-carotene yield versus CAR001, and 8% improve-
ment of β-carotene yield versus parent strain (Figs. 3, 5; 
Additional file  1: Table S2). This result illustrated that 
modulating gene with a library of regulatory parts led to 
a wider variation in expression strength than using lim-
ited regulatory parts with fixed strengths, provided more 
possibilities to obtain optimal efficiency for pathways. 
Furthermore, a comparison was made between modulat-
ing gene expression from a single strain or from a pool 
of mixed strains in modulating Hmg1 RBSs. β-carotene 
production of strains derived from a pool was generally 
higher than that from a single strain, probably due to 
similar reasons as above, that more combinations were 
achieved with parent strains in a mixture pool. This result 
inspired us to develop methods to build metabolic engi-
neering libraries with more random regulatory parts in 
higher mathematic dimensions to achieve better possi-
bilities for optimal expression combinations.
In this study, a genetically stable E. coli strain with high 
β-carotene production was obtained by combined engi-
neering of MEP and MVA (Fig.  5). A genetically stable 
chassis with activated MEP and MVA pathways for IPP 
and DMAPP precursor supply to produce various terpe-
nes was obtained. Our study provided a novel strategy 
Table 2 Calculated strength of mvaS and Hmg1 RBS from strains from re-modulation libraries
a  Value of strength was represented by the translation initiation rate calculated by RBS library calculator [29, 30]










Hmg1-RBSL-2 AGGAGAGAGAGG 408 AGGAGAAACAAC 3877 0.93
Hmg1-RBSL-3 AGGAGAGAGAGG 408 AGGAGGGAAAAA 9975 0.98
Hmg1-RBSL-6 AGGAGAGAGAGG 408 AGGAGAACAGCT 3238 1.00
Hmg1-RBSL-M3 AGGAGGGTATCG 2159 AGGAGGATAAAG 7965 1.09
Hmg1-RBSL-11 AGGAGAGAGAGG 408 AGGAGGAAAAAC 12,720 1.11
Hmg1-RBSL-M1 AGGAGACAAAAG 1099 AGGAGACAAAAG 2656 1.26
Hmg1-RBSL-15 AGGAGAGAGAGG 408 AGGAGGAAAAGG 4855 1.31
Hmg1-RBSL-M10 AGGAGAGGACTG 612 AGGAGAACAGCT 3238 1.52
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for improving production of a target compound through 
integration and subsequent modulation of heterologous 
pathways by changes in both promoters and RBSs.
Conclusions
In this study, MVA pathway was divided into three 
modules, integrated into the E. coli chromosome, and 
individually modulated with regulatory parts to opti-
mize efficiency of the pathway in terms of downstream 
isoprenoid production. Hmg1-erg12 operon and mvaS-
mvaA-mavD1 operon were integrated into E. coli chro-
mosome followed by modulation with promoters with 
varied strength, resulting in a 26% increase of β-carotene 
production with no effect on cell growth. With a combi-
natory modulation of two key enzymes mvas and Hmg1 
with degenerate RBS library, β-carotene showed a further 
increase of 51%.
Our study provides a novel strategy for improving 
production of a target compound through integration 
and modulation of heterologous pathways in both tran-
scription and translation level. In addition, a genetically 
hard-coded chassis with both efficient MEP and MVA 
pathways for isoprenoid precursor supply was con-
structed in this work.
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